Friday, October 30, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 7, 2025

Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa

View original at globenewswire.com
Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa LONDON, Ontario, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Europe opens unique opportunities to strengthen collaboration along the entire value chain

    80% confidence
  • Using a brownfield site reduces project risk and capital requirements by simplifying integration of permits, land use plans, and utilities while achieving operational readiness faster

    80% confidence
  • The fact that the region hosts a multitude of chemical industry producers, processors, and recycling companies provides a solid foundation for expanding collaboration with potential partners and customers

    80% confidence
  • The company expects to make a final site decision in January 2026

    80% confidence
  • This structured approach reduces execution risk and continues to focus on process integration, performance validation, and customer engagement

    80% confidence
  • The approach reflects the adaptability of Hydrochemolytic Technology to existing industrial facilities where conventional thermal systems can be modernized with water-based chemistry at lower temperatures, leveraging benefits of existing infrastructure and supply chains

    80% confidence
  • The property has potential for future expansion to capacity of up to 25,000 tonnes per year

    80% confidence
  • Establishing a demonstration plant in the Netherlands will help validate performance at scale and accelerate processes that turn technical success into commercial application

    80% confidence
  • The team is applying the same disciplined approach used in developing the NGP pilot plant, seeking a site that meets rigorous evaluation standards while keeping options open for future commercial-scale expansion

    80% confidence
  • The LOI is another important step on the path from pilot to demonstration plant and ultimately to commercialization

    80% confidence

Data points we hold from this source

Aduro Clean Technologies Inc. · demonstration plant capacity25000 tonnes_per_year
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com
Aduro Clean Technologies unterzeichnet unverbindliche Absichtserklärung für Demonstrationsanlage in Europa — Source | Via News | Finance Via News